Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
出版年份 2021 全文链接
标题
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
作者
关键词
-
出版物
LANCET NEUROLOGY
Volume 20, Issue 6, Pages 484-496
出版商
Elsevier BV
发表日期
2021-04-30
DOI
10.1016/s1474-4422(21)00066-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The characterisation of subjective cognitive decline
- (2020) Frank Jessen et al. LANCET NEUROLOGY
- Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease
- (2020) Rik Ossenkoppele et al. JAMA Neurology
- The implications of different approaches to define AT(N) in Alzheimer disease
- (2020) Niklas Mattsson-Carlgren et al. NEUROLOGY
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
- (2020) Adam S. Fleisher et al. JAMA Neurology
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ATN classification and clinical progression in subjective cognitive decline
- (2020) Jarith L. Ebenau et al. NEUROLOGY
- Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults
- (2020) Shama Karanth et al. JAMA Neurology
- Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study
- (2020) Hana Saddiki et al. PLOS MEDICINE
- Endosomal recycling reconciles the Alzheimer’s disease paradox
- (2020) Scott A. Small et al. Science Translational Medicine
- Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
- (2019) Iris E. Jansen et al. NATURE GENETICS
- Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis
- (2019) Lucilla Parnetti et al. Alzheimers Research & Therapy
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
- (2019) Brian W. Kunkle et al. NATURE GENETICS
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
- (2019) Peter T Nelson et al. BRAIN
- Alzheimer's Disease Including Focal Presentations
- (2019) Nicolas Villain et al. SEMINARS IN NEUROLOGY
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project
- (2019) Ingrid S. van Maurik et al. Alzheimers Research & Therapy
- Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
- (2019) Laurent Younes et al. Frontiers in Aging Neuroscience
- Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia
- (2019) Clifford R. Jack et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Determining clinically meaningful decline in preclinical Alzheimer disease
- (2019) Philip S. Insel et al. NEUROLOGY
- Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression
- (2019) Filip Liebsch et al. Nature Communications
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
- (2019) Tessa Timmers et al. Alzheimers Research & Therapy
- How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years
- (2019) Stéphane Epelbaum et al. BMJ Open
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
- (2019) Bernard J. Hanseeuw et al. JAMA Neurology
- Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study
- (2019) Jin-Tai Yu et al. Alzheimers & Dementia
- Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
- (2019) Anna Antonell et al. Alzheimers & Dementia
- Re-aligning scientific and lay narratives of Alzheimer's disease
- (2019) Giovanni B Frisoni et al. LANCET NEUROLOGY
- Amyloid-β-independent regulators of tau pathology in Alzheimer disease
- (2019) Rik van der Kant et al. NATURE REVIEWS NEUROSCIENCE
- Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease
- (2019) Gil D. Rabinovici et al. JAMA Internal Medicine
- Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
- (2019) Elena Chipi et al. Brain Sciences
- Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
- (2018) Ron Brookmeyer et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease
- (2018) Lorraine Hamelin et al. BRAIN
- Longitudinal tau PET in ageing and Alzheimer’s disease
- (2018) Clifford R Jack et al. BRAIN
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
- (2018) John L Robinson et al. BRAIN
- Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years
- (2018) Marilyn Albert et al. BRAIN
- Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort
- (2018) Ellis Niemantsverdriet et al. JOURNAL OF ALZHEIMERS DISEASE
- Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
- (2018) Bruno Dubois et al. LANCET NEUROLOGY
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Resistance vs resilience to Alzheimer disease
- (2018) Eider M. Arenaza-Urquijo et al. NEUROLOGY
- The genes associated with early-onset Alzheimer’s disease
- (2018) Meng-Hui Dai et al. Oncotarget
- Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults
- (2018) Jessica Mozersky et al. JAMA Neurology
- Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia
- (2018) David Bergeron et al. ANNALS OF NEUROLOGY
- Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
- (2018) Rosalinde E.R. Slot et al. Alzheimers & Dementia
- Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
- (2018) Renaud La Joie et al. Alzheimers & Dementia
- Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
- (2018) Dallas P. Veitch et al. Alzheimers & Dementia
- Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease
- (2018) W. Robert Bell et al. Alzheimers & Dementia
- On the reconceptualization of Alzheimer’s disease
- (2018) Maartje H. N. Schermer et al. BIOETHICS
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
- (2017) Anne Maass et al. NEUROIMAGE
- Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly
- (2017) Jacob W. Vogel et al. NEUROLOGY
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Neuropathological comorbidity associated with argyrophilic grain disease
- (2017) Osamu Yokota et al. NEUROPATHOLOGY
- Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
- (2017) Rahul S. Desikan et al. PLOS MEDICINE
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
- (2016) Bruno Dubois et al. Alzheimers & Dementia
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
- (2016) Samantha C Burnham et al. LANCET NEUROLOGY
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
- (2015) Jon B. Toledo et al. BRAIN
- Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
- (2015) Sylvia Villeneuve et al. BRAIN
- The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
- (2015) Rik Ossenkoppele et al. BRAIN
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer’s Disease
- (2015) Ashish Raj et al. Cell Reports
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
- (2014) Christiane Reitz et al. BIOCHEMICAL PHARMACOLOGY
- Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia
- (2014) M.-Marsel Mesulam et al. BRAIN
- Mild Cognitive Impairment and Asymptomatic Alzheimer Disease Subjects
- (2014) Diego Iacono et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Subjective cognitive decline: Self and informant comparisons
- (2013) Richard J. Caselli et al. Alzheimers & Dementia
- Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
- (2013) Beatriz G. Perez-Nievas et al. BRAIN
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- Subjective memory complaints in elders: depression, anxiety, or cognitive decline?
- (2012) Y. Balash et al. ACTA NEUROLOGICA SCANDINAVICA
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
- (2012) Nicolas Villain et al. BRAIN
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Clinicopathological correlations in corticobasal degeneration
- (2011) Suzee E. Lee et al. ANNALS OF NEUROLOGY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Resolving controversies on the path to Alzheimer's therapeutics
- (2011) Dennis J Selkoe NATURE MEDICINE
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started